|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||
| Current assets: | ||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||
| Marketable securities, available for sale | ||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||
| Total current assets | ||||||||||||||||
| Property and equipment, net | ||||||||||||||||
| Other non-current assets | ||||||||||||||||
| Total assets | ||||||||||||||||
| Liabilities and stockholders' equity | ||||||||||||||||
| Liabilities | ||||||||||||||||
| Current liabilities: | ||||||||||||||||
| Accounts payable | ||||||||||||||||
| Accrued expenses | ||||||||||||||||
| Total current liabilities | ||||||||||||||||
| Non-current liabilities: | ||||||||||||||||
| Long-term debt, net of discount | ||||||||||||||||
| Restricted stock repurchase liability | ||||||||||||||||
| Total liabilities | ||||||||||||||||
| Stockholders' equity: | ||||||||||||||||
| Preferred stock, $0.0001 par value; 10,000,000 shares authorized as of March 31, 2025 and December 31, 2024; no shares issued or outstanding as of March 31, 2025 and December 31, 2024 | ||||||||||||||||
| Common stock, $0.0001 par value; 500,000,000 shares authorized as of March 31, 2025 and December 31, 2024; 59,316,859 and 59,198,230 shares issued as of March 31, 2025 and December 31, 2024, respectively; 59,223,729 and 59,131,149 shares outstanding as of March 31, 2025 and December 31, 2024, respectively | ||||||||||||||||
| Additional paid-in capital | ||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||
| Treasury stock, 93,130 and 67,081 shares as of March 31, 2025 and December 31, 2024, respectively; at cost | ||||||||||||||||
| Accumulated deficit | ||||||||||||||||
| Total stockholders' equity | ||||||||||||||||
| Total liabilities and stockholders' equity |
Loading...
